Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia.

Biological psychiatry - 15 Jun 1998

Zorrilla E P, Cannon T D, Kessler J, Gur R E

Abstract excerpt

BACKGROUND: The majority of patients with schizophrenia and many of their unaffected siblings exhibit a relative granulocytosis and lymphopenia. To characterize these abnormalities better, we examined leukocyte differentials and organ nonspecific autoantibodies in relationship to intake phenomeno...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Granulocytes
Share to Leukocyte Count
Share to Leukocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Psychiatric Status Rating Scales

Share to Schizophrenia

Share to Treatment Outcome

Source

Identifiers

PMID: 9627743
DOI: 10.1016/s0006-3223(97)00358-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9627743-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia.PMID 9627743Read ↗

Leukocytes and organ-nonspecific autoantibodies in schizophrenics and their siblings: markers of vulnerability or disease?Semantic proximity Read ↗

Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.Semantic proximity Read ↗

The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.Semantic proximity Read ↗

Pan T cells, Helper T cells, and Regulatory T cells are Associated with Negative Symptoms in Persons with Anti-Gliadin Antibody Positive Schizophrenia and Related DisordersSemantic proximity Read ↗

Monocytic Subsets and Their Signature Genes Differentially Impact Cortex and Cognition in First-Episode SchizophreniaSemantic proximity Read ↗

Associations of Systemic Inflammation and Senescent Cell Biomarkers with Clinical Outcomes in Older Adults with SchizophreniaSemantic proximity Read ↗

Altered immune function in unaffected first-degree biological relatives of schizophrenia patientsSemantic proximity Read ↗

Distinct Molecular Phenotypes in Male and Female Schizophrenia PatientsSemantic proximity Read ↗

A new schizophrenia model: immune activation is associated with induction of the tryptophan catabolite pathway and increased eotaxin levels which together determine memory impairments and schizophrenia symptom dimensionsSemantic proximity Read ↗

Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severitySemantic proximity Read ↗

Schizophrenia Phenomenology Comprises a Bifactorial General Severity and a Single-group Factor, Which Are Differently Associated with Neurotoxic Immune and Immune-regulatory PathwaysSemantic proximity Read ↗

In Schizophrenia, Low Natural IgM Antibody Titers to Oxidative Specific Epitopes and Higher IgM Responses to Nitrated and Nitrosylated Proteins Strongly Predict Negative Symptoms, Neurocognitive Impairments and the Deficit SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.